New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Thermo Fisher Scientific Inc.
TMO
Shape
US Flag

NYSE

196B

Medical - Diagnostics & Research

Next Earning date - 23 Apr 2025

196B

Medical - Diagnostics & Research

Next Earning date - 23 Apr 2025

531.85USD

Shape-0.79 ( -0.15%)
moonAfter-hours 519.99$arrow-right-up0.09 (0.02%)
Market Closed (as of Feb 14, 21:00 EDT)
favorite-chart

Relative Strenght

32
favorite-chart

Volume Buzz

-27%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

15%

Quote Panel

Shape
Updated March 24, 2025
1W -0.31 % 1M -3.56 % 3M -1.30 % 1Y -9.09 %

Key Metrics

Shape
  • Market Cap

    196.14B


  • Shares Outstanding

    377.26M


  • Share in Float

    376.61M


  • Dividende

    1.6


  • Earning Date

    23 Apr 2025


  • Price Target

    519.9


  • Average Volume

    1.91M


  • Beta

    0.789


  • Range

    493.3-627.88


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.thermofisher.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

TMO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$44B

Shape285%

2025-Revenue

$23.30

Shape387%

2025-EPS

$13B

Shape321%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

639.00(22.91%)

Number of analyst

2

Last analyst upgrade/downgrade

Bernstein

upgrade

Previous: Not converted

2025-01-10

Now: Outperform

Stephens

initialise

Previous: Not converted

2024-09-30

Now: Overweight

Wells Fargo

initialise

Previous: Underweight

2024-08-27

Now: Overweight

Jefferies

upgrade

Previous: Not converted

2024-06-03

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.23

arrow
arrow

-31%

5.03
vs 7.25

Q3.23

arrow
arrow

-7%

5.15
vs 5.51

Q3.23

arrow
arrow

+3%

5.69
vs 5.51

Q4.23

arrow
arrow

+5%

5.67
vs 5.4

Q1.24

arrow
arrow

N/A

5.11
vs NA

Q2.24

arrow
arrow

+7%

5.37
vs 5.03

Q3.24

arrow
arrow

-7%

5.28
vs 5.69

Q4.24

arrow
arrow

+8%

6.1
vs 5.67

Q1.25

arrow
arrow

+0%

5.11
vs 5.11

Q2.25

arrow
arrow

+4%

5.6
vs 5.37

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.23

arrow
arrow

-9%

10.7B  vs 11.8B

Q3.23

arrow
arrow

-3%

10.7B  vs 11B

Q3.23

arrow
arrow

-4%

10.6B  vs 11B

Q4.23

arrow
arrow

-5%

10.9B  vs 11.4B

Q1.24

arrow
arrow

NA

10.3B  vs NA

Q2.24

arrow
arrow

-2%

10.5B  vs 10.7B

Q3.24

arrow
arrow

+0%

10.6B  vs 10.6B

Q4.24

arrow
arrow

+5%

11.4B  vs 10.9B

Q1.25

arrow
arrow

-1%

10.2B  vs 10.3B

Q2.25

arrow
arrow

+2%

10.8B  vs 10.5B

Return on EquityShape

status-upQoQ

Q2.23

arrow
arrow

+3%

0.03
vs 0.04

Q3.23

arrow
arrow

+3%

0.03
vs 0.03

Q3.23

arrow
arrow

+4%

0.04
vs 0.03

Q4.23

arrow
arrow

+3%

0.03
vs 0.04

Q1.24

arrow
arrow

+3%

0.03
vs 0.03

Q2.24

arrow
arrow

+3%

0.03
vs 0.03

Q3.24

arrow
arrow

+3%

0.03
vs 0.03

Q4.24

arrow
arrow

+4%

0.04
vs 0.03

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

2428

2.4K
vs 2.4K

0%

Q2.23

arrow
arrow

2441

2.4K
vs 2.4K

1%

Q3.23

arrow
arrow

2415

2.4K
vs 2.4K

-1%

Q4.23

arrow
arrow

2547

2.5K
vs 2.4K

5%

Q1.24

arrow
arrow

2573

2.6K
vs 2.5K

1%

Q2.24

arrow
arrow

2588

2.6K
vs 2.6K

1%

Q3.24

arrow
arrow

2618

2.6K
vs 2.6K

1%

Q4.24

arrow
arrow

2624

2.6K
vs 2.6K

0%

Earnings Growth

Latest News